Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ribonucleoside reductase transcription inhibition factor mutant, mutation gene and application of ribonucleoside reductase transcription inhibition factor mutant and mutation gene to preparation of vitamin B2

A technology of transcriptional inhibitors and ribonucleotides, which is applied in the biological field, can solve problems such as ribonucleotide reductase transcriptional inhibitors mutants, and achieve great application value and improve the effect of ability

Active Publication Date: 2020-07-10
TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no ribonucleotide reductase transcriptional inhibitor mutant gene wxya ( wxya ) for vitamin B 2 synthetic report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ribonucleoside reductase transcription inhibition factor mutant, mutation gene and application of ribonucleoside reductase transcription inhibition factor mutant and mutation gene to preparation of vitamin B2
  • Ribonucleoside reductase transcription inhibition factor mutant, mutation gene and application of ribonucleoside reductase transcription inhibition factor mutant and mutation gene to preparation of vitamin B2
  • Ribonucleoside reductase transcription inhibition factor mutant, mutation gene and application of ribonucleoside reductase transcription inhibition factor mutant and mutation gene to preparation of vitamin B2

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1: bacterial strain CGMCC NO.16132 and BS168 ribC m Perform comparative genomic analysis

[0030] strain BS168 ribC m (For the specific construction process, please refer to Chinese patent application 201910604170.3), the genome was used as the reference genome, and the strain CGMCC NO. 16132 was sent to Jinweizhi Biotechnology Co., Ltd. for whole-genome resequencing and differential analysis to find out the effect on vitamin B production. 2 Ability-affected genes. Through sequence comparison analysis, it was found that the strain CGMCC NO. 16132 had a large number of mutations, including a total of 338 mutation sites: after mutation statistics, a total of 72 genes were involved in the mutation. Mutations in the coding region involved a total of 59 genes, including 8 synonymous mutations, 41 non-synonymous mutations, 2 nonsense mutations, 5 frameshift mutations, and 3 non-frameshift mutations; mutations in non-coding regions A total of 13 genes were involv...

Embodiment 2

[0032] Embodiment 2: Construct containing wxya mutant strain

[0033] by Bacillus subtilis Chromosome 168 was used as a template, primers UPnrdR-F and UPnrdR-R (including DR) were used to amplify the UPnrdR (including DR) fragment with adapter, and primers araR-F and araR-R (including DR) were used to amplify the araR with adapter ( DR) fragment; use the pC194 plasmid as a template, use primers cat-F, cat-R to amplify the cat fragment with linker; use the chromosome of strain CGMCC NO. 16132 as a template, use primer nrdR m -F, nrdR m -R amplifies nrdR with a point mutation m Fragment, wherein the mutated wxya The nucleotide sequence is shown in SEQ ID No.2, and the encoded amino acid sequence is shown in SEQ ID No.4.

[0034] Take UPnrdR fragment, cat fragment, araR fragment and nrdR m Fragment as template, use primers UPnrdR-F, nrdR m -R for fusion PCR to obtain the assembly fragment UCR-nrdR m , was detected correctly by nucleic acid electrophoresis, and purified...

Embodiment 3

[0043] Example 3: Evaluation of B vitamins in different strains 2 production capacity

[0044] 1. Strain culture conditions:

[0045] Will start strain BS168 ribC m , and engineering strain BS168 nrdR m Under sterile conditions, the LB solid plate containing 25 mg / L erythromycin was streaked with an inoculation needle, and cultured upside down in a 37°C incubator for 24 hours to obtain freshly activated single colonies. Pick a single colony with an inoculation needle and streak the LB solid slope containing 25 mg / L erythromycin, and culture it in a 37°C incubator for 48 hours. Scrape 1 / 3 of the bacterial lawn on the inclined surface and inoculate it into a 500mL baffled Erlenmeyer flask containing 70mL of fermentation medium (3 parallels for each strain of bacteria), shake culture at 37°C and 200rpm for 41h, then take the fermentation broth to measure OD 600 and vitamin B 2 Yield.

[0046] , OD of different strains 600 and vitamin B 2 Yield Comparison

[0047] with th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a ribonucleoside reductase transcription inhibition factor mutant, a mutation gene and an application of the ribonucleoside reductase transcription inhibition factor mutant andthe mutation gene to preparation of vitamin B2. The amino acid sequence of the mutant is subjected to the following mutation relative to the sequence as shown in SEQID No.3; and an amino acid at the26th site is replaced with H. For the nucleotide fixed point mutation that the amino acid at the 26th site, coded in the ribonucleoside reductase transcription inhibition factor gene on a bacillus subtilis chromosome is replaced with H, a genetic engineering bacterium is obtained, and the capacity for producing the vitamin B2 is greatly improved. The ribonucleoside reductase transcription inhibition factor mutant has great application and extension value.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular to a mutant of ribonucleotide reductase transcription inhibitor, its genetically engineered bacteria and vitamin B 2 in the application. Background technique [0002] riboflavin aka vitamin B 2 , is a water-soluble B vitamin that most microorganisms and plants can synthesize independently, while humans and animals can only ingest it from food. Riboflavin mainly exists in the form of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in the body, and it is used as a coenzyme or prosthetic group of flavoprotein to participate in the electron transfer and oxidation of the respiratory chain of the body tissue Reduction reaction is an essential nutrient for maintaining normal metabolism and physiological functions of the body. Riboflavin is widely used in the fields of medicine, food and feed. Due to the wide use of riboflavin, the demand for riboflavin at home and abroad i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/32C12N15/31C12N15/75C12N1/21C12P25/00C12R1/125
CPCC07K14/32C12N15/75C12P25/00
Inventor 张大伟夏苗苗刘川孙宜文
Owner TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com